Investigator-Initiated Research Award –HT942526TERPIIRA
- Pre-proposals due 19 August 2026
- Up to USD$800,000 over 3 years
- Supports studies that will make an important contribution to research and/or patient care for a disease or condition associated with military-related toxic exposures.
- Projects may range from basic laboratory research through translational research, including preclinical studies in animal models and human subjects, as well as correlative studies associated with existing clinical trials.
- collaboration with military and/or VA researchers and clinicians encouraged
- research involving human subjects and human anatomical substances allowed
- clinical trials not allowed
- preliminary data required
- Must address at least one of the program goals and at least one of the topic areas
- Apply here
- Document – Program Announcement – HT942526TERPIIRA_GG
Translational Research Award – HT942526TERPTRA
- Pre-proposals due 19 August 2026
- Up to USD$1.5M over 3 years
- Supports translational research that will accelerate the movement of promising ideas in military-related toxic exposure research into clinical applications, including health care products, interventions, technologies and/or clinical practice guidelines.
- collaboration with military and/or VA researchers and clinicians encouraged
- participation of at least one military or veteran consumer as part of the research team strongly encouraged
- preclinical studies (including involving animals) and/or clinical research allowed
- clinical trials not allowed
- preliminary data required
- Must address at least one of the program goals and at least one of the topic areas
- Apply here
- Document – Program Announcement – HT942526TERPTRA_GG
Clinical Trial Award – HT942526TERPCTA
- Pre-proposals due 19 August 2026
- Up to USD$4.5M over 4 years
- Supports the rapid implementation of clinical trials with the potential to significantly impact prevention, treatment or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures.
- Projects may range from small proof-of-concept trials through large-scale, definitive trials, including pragmatic clinical trials, to determine efficacy in relevant patient populations.
- Supports clinical trials designed to evaluate promising new products; pharmacologic agents, such as drugs or biologics; devices; clinical guidance; and/or emerging approaches and technologies.
- initiation of proposed clinical trials within 12 to 18 months of the award date expected
- pre-clinical studies not allowed
- animal research not allowed
- collaboration with military and/or VA researchers and clinicians encouraged
- participation of at least one military or veteran consumer as part of the research team strongly encouraged
- inclusion of at least one clinician on the study team encouraged
- preliminary data required
- Must address at least one of the program goals and at least one of the topic areas
- Apply here
- Document – Program Announcement – HT942526TERPCTA_GG
